Disease relevance of Pacemaker, Artificial

• It is concluded that (1) atrial contraction is important to the LV function in patients with artificial pacemakers, and (2) that favorable effects on the LV function can be obtained by a small dose of digoxin administered to the patients who had artificial pacemakers but no congestive heart failure [1].
• A 30-year-old woman with an artificial cardiac pacemaker was taking warfarin to prevent thromboembolism [2].
• In this case re-exposure with a recommended dose of propofol was accompanied by bradycardia and dysrythmias that proved to be resistant to therapy and led to fatal cardiac insufficiency with a functioning artificial pacemaker in place [3].
• Different response of left ventricular dimensions to nitroglycerin in patients with artificial pacemaker. A possible significance of reflex tachycardia for the reduction of LV cavity after nitroglycerin [4].

High impact information on Pacemaker, Artificial

• Dual chamber (DDD) or "universal" pacemakers have had a significant impact on the advancement of artificial pacemakers by providing a more physiologic approach to cardiac pacing [5].
• Atrial natriuretic peptide with artificial pacemakers [6].
• Indications for and use of artificial cardiac pacemakers: Part I [7].
• Artificial pacemaker patients--treatment outcome and the Sixteen Personality Factor Questionnaire [8].

Biological context of Pacemaker, Artificial

• The contribution of atrial systole in the left ventricular (LV) function and the effects of oral digoxin maintenance therapy on the LV function were evaluated noninvasively in patients who had artificial pacemakers but no clinical manifestation of congestive heart failure (NYHA Class I) [1].

Associations of Pacemaker, Artificial with chemical compounds

• Favorable effects of oral digoxin therapy on the left ventricular performance in patients with artificial pacemakers [1].

References